Telemark discloses 4.1% Biodesix (BDSX) stake in final Schedule 13G/A
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Telemark Asset Management, Telemark Fund and Colin McNay have filed an Amendment No. 1 to their Schedule 13G for Biodesix, Inc., which they state is a final, “exit” filing. The reporting persons may be deemed to beneficially own 327,824 shares of Biodesix common stock, representing approximately 4.1% of the outstanding shares as of the event date.
All 327,824 shares are reported with shared voting and shared dispositive power and no sole voting or dispositive power. The filers certify that the securities were not acquired and are not held for the purpose of changing or influencing control of Biodesix, but instead under the passive ownership standard applicable to Schedule 13G.
Positive
- None.
Negative
- None.
FAQ
What does the Telemark Schedule 13G/A say about its Biodesix (BDSX) ownership?
The filing states that Telemark Asset Management, Telemark Fund and Colin McNay may be deemed to beneficially own 327,824 shares of Biodesix common stock, representing approximately 4.1% of the outstanding shares.
Why is this Biodesix (BDSX) Schedule 13G/A labeled an exit filing?
The amendment notes that it amends in its entirety the prior Schedule 13G and that it is the final amendment, explicitly stating that it constitutes an exit filing for the reporting persons.
Does Telemark state an intent to influence control of Biodesix (BDSX)?
No. The certification states the securities were not acquired and are not held for the purpose of changing or influencing control of Biodesix and are not held in connection with any such transaction, consistent with a passive Schedule 13G filing.
Who are the reporting persons in this Biodesix (BDSX) Schedule 13G/A?
The amendment is jointly filed by Telemark Asset Management, LLC, Telemark Fund, LP, and Colin S. McNay. Telemark Asset Management is the investment adviser to Telemark Fund, and McNay is Telemark Asset Management’s president and sole owner.
What percentage threshold does the Biodesix (BDSX) 13G/A reference?
Item 5 indicates ownership of 5 percent or less of the class, with the reported beneficial ownership at approximately 4.1% of Biodesix’s outstanding common stock.